It is there present in significantly higher concentrations and correlates with the type of bile duct disease (low CEA levels correlate with benign lesions, intermediate with primary sclerosing cholangitis, and high levels correlate with CCA and intrahepatic stones) [97]. Here, CEACAM5 is linked to cholangiocarcinoma.